| |
|
|
|
Cancer Genetics Inc.  
|
|
0.2605 -0.005 (-0.02%) |
03-22 16:00 |
|
Open: |
0.27 |
Pre close: |
0.266 |
Target:
|
0.34
|
|
High: |
0.2728 |
Low: |
0.2561 |
Resistance:
|
0.29
0.34
|
|
Volume: |
985,355 |
Market Cap: |
15M |
Support:
|
0.25
0.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.27
 |
MACD |
MACD(12,26):
|
-0.00  |
|
MA(20): |
0.26 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
0.34 |
Stochastic Oscillator |
%K(14,3):
|
42.08 |
|
MA(250): |
0.74 |
%D(3): |
45.51 |
|
Average Volume(K) |
3-Month: |
223615
|
52-Week |
High:
|
1.85 |
|
10-Days: |
118380 |
Low: |
0.20 |
|
RSI |
RSI(14):
|
48.06 |
Change(%): |
-85.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.870 |
Return on Equity (ttm) |
-121.4 |
Shares Out. (M) |
56.28 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-52.2 |
Shares Float (M) |
50.43 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
-0.01 |
% Held by Insiders |
21.10 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-26.0 |
% Held by Institutions |
5.30 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.550 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.30 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.17 |
|
Profit Margin |
-80.45 |
Operating Cash Flow
(M) |
-14.75 |
P/S |
13574945.00 |
|
Operating Margin |
-85.83 |
Levered Free Cash Flow
(M) |
-0.29 |
P/CF |
-0.99 |
|
|
|
|
|
|
